Ignite Creation Date:
2024-05-06 @ 7:57 AM
Last Modification Date:
2024-10-26 @ 11:54 AM
Study NCT ID:
NCT02638909
Status:
TERMINATED
Last Update Posted:
2018-04-02
First Post:
2015-12-15
Brief Title:
Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies
Sponsor:
Criterium Inc
Organization:
Criterium Inc
Organization Data
Organization:
Criterium Inc
Class:
INDUSTRY
Study ID:
NOV-ALK-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Criterium Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis | INDUSTRY |
| University of Colorado Denver | OTHER |